/PRNewswire/ AuraVax Therapeutics, Inc., a biotechnology company developing novel immunotherapies to prevent and treat respiratory viruses, today announced.
In an effort that has been underway for several years and is now set against a backdrop of triple-digit oil prices, oil and gas companies are continuing attempts to devise new methods of increasing production from existing unconventional wells.